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LOCAL ANESTHETIC SOLUTIONS IN DENTISTRY: A COMPARATIVE STUDY
Material and methods
In order to carry out the study, there were studied a large number of dental books –
14 and  foreign clinical studies from PubMed – 7, researchgate – 4, emedicine – 5
and US Library – 6.
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Purpose: Analysis of specialty literature to determine if  articaine or 
lidocaine is more effective. 
Results
The chemical and pharmacologic properties of a local anesthetic can give valuable 
information about the clinical effects . The most important ones for both articaine 
and lidocaine are listed in Table 1.
The dissociation constant (pKa) affects the onset of action. Lower pKa, means that 
more molecules are present to diffuse through the nerve, thus the onset time is 
decreased. 
Introduction
Pain control requires the study of local anesthesia. Local anesthetics have been
available in dentistry since 1884 and today lidocaine and articaine are most
often used. The main question is which one is more suitable and presents more
advantages.




Lipid solubility 4.0 17.0
Protein binding, % 65 95
Metabolism Liver Liver, blood
Half – life, min 90 27
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Table 1. Physicochemical and pharmacologic properties 
of lidocaine and articaine.
Lipid solubility affects the anesthetic potency. Increased lipid solubility enhances 
diffusion through the nerve, which itself is 90 % lipid (Malamed 2013), more easily. 
Articaine differs from lidocaine,because it contains both ester and amide linkages. 
As a result, it is more lipid soluble (Isen 2000). 
Protein binding affects the duration. Increased protein binding allows anesthetic 
cations to be more firmly attached to proteins located at receptor sites. Thus the 
duration of action is increased.
Approximately 70 % of lidocaine undergoes liver biotransformation . Patients with  
poor liver function are unable to biotransform it at a normal rate. This leads to  
increased toxicity. The extra ester linkage in articaine alows it to be  90-95 %  
metabolized with the help of the cholinesterase enzyme in blood, and only 5-10 % in 
the liver. This feature is clearly demonstrated when  the half-life  between articaine 
and lidocaine is compared, 27 min versus 90 min.
Malamed & al conducted a study to compare the safety between articaine 4 % with 
adrenaline 1:100 000, and lidocaine 2 % with adrenaline 1:100 000. A total of 1325 
subjects participated in these study, 882 in the articaine group, and 443 in the 

























Lidocaine is considered to be more safe, being administrated to children under 4, 
pregnant woman and allergic pacients, but articaine has a 1,5 times bigger potency, 
it diffuses faster, binds better with the plasmatic proteins and also is better for 
pacients with liver problems. 
Paraesthesia is the most common side effect of articaine (Jacques A. Baart), but 
lidocaine also can cause adverse events, which must be taken in consideration.
If we have a standard patient, then articaine will  be more suitable to use.
